Category Archives

10 Articles

Bionano Lab. en la Noche Europea de los Investigadores

Posted by a3p on


Juan Molina y Óscar Malvar del grupo de Bionanomecánica (IMN-CSIC) enseñaron a posibles futuros investigadores el “Show del muelle” durante la Noche Europea de los Investigadores en la sede central del CSIC. La charla divulgativa explicó a los más jovenes cómo pesar virus y bacterias con resonadores nanomecáncios, recalcando la importancia de la ciencia en la sociedad.[:]

Montserrat Calleja, winner of the Jaume I award in New Technologies 2022

Posted by a3p on
Montserrat Calleja, winner of the Jaume I award in New Technologies 2022

Montserrat Calleja Gómez has been awarded the Rei Jaume I Prize in New Technologies 2022 for her work in the application of the main advances in basic research in physics to practical innovations in the clinical field. Specifically, the awards jury highlighted her work on biomolecular markers and nanomechanical sensors for the early detection of cancer and infectious diseases. Calleja is a CSIC research professor at the Institute of Micro and Nanotechnology (IMN-CNM-CSIC) in Madrid.

The award was announced at the proclamation ceremony of the 34th edition of the Rei Jaume I Awards, which was held today at the Palau de la Generalitat in the city of Valencia and presided over by the head of the Consell, Ximo Puig. The event was attended by the founding president of the awards, Santiago Grisolía; the executive president, Javier Quesada; and the vice president of the Rei Jaume I Awards Foundation, Vicente Boluda. The president of the CSIC, Rosa Menéndez, and the delegate of the CSIC in the Valencian Community, Juan Fuster, also attended.

Mecwins announces licensing and co-development agreement with Quidel

Posted by a3p on

Mecwins, company founded by Bionanomechanics Lab researchers and licensee of several patents of the group, Announces Strategic Partnership to Develop a Next Generation Platform for Point of Care (POC) Testing
This licensing and co-development agreement leverages Mecwins’ ultrasensitive AVAC platform and Quidel’s extensive expertise in POC assay and cartridge development.
Ultrasensitive POC testing will facilitate developing new tests, incorporating biomarkers and indications not possible with current technologies. Quidel got first FDA approved antigent test for SARS-COV-2.
06/15/2021, Madrid, Spain – Mecwins announced that it has entered into a licensing and co-development agreement with Quidel Corporation, a leading manufacturer of diagnostic solutions at the point of care, to jointly develop a new testing platform capable of detecting and quantifying biomarkers in concentrations below picogram per ml level in the POC setting. This technology will enable the development of new tests requiring extreme sensitivity.

Mecwins will use its high throughput ultrasensitive AVAC technology and expertise to develop a POC analyzer according to Quidel´s requirements and Quidel will use its extensive expertise in cartridge and immunoassay development to design integrated POC tests that support multiple biological sample types.

The approach will use a combination of localized plasmonic resonance detection with a standard sandwich immunoassay format. Financial and other terms of the collaboration were not disclosed, but both companies have been collaborating since December 2019.

“Ultrasensitive detection and quantification will be a new area of biomarker discovery and validation. Ultrasensitive technologies, below picogram per ml level, are now being used for new biomarker discovery in multiple diagnostic indications: infectious disease, cardiac, inflammation, autoimmune, cancer, etc. Taking it near the patient in a POC setting for an immunodiagnostic assay represents a challenge, but also a great opportunity to develop tests for better, faster clinical decisions,” said Douglas Bryant, Quidel Chief Executive Officer.

Mecwins Chief Executive Officer, Oscar Ahumada, commenting on this agreement said that “this agreement validates Mecwins’ approach to develop ultrasensitive technologies for biomarker detection. Having the opportunity to collaborate with Quidel will allow us to access Quidel expertise in assay development and accelerate development and market introduction”.[:]

Presentation of the #AlianzaSTEAM for female talent

Posted by a3p on

Presentation of the #AlianzaSTEAM for female talent. The Ministry of Education and Vocational Training and more than fifty entities come together to promote scientific-technological vocations among girls and young people. Live interventions by Minister Isabel Celaá, Carmen Fenoll, Montserrat Calleja, Nuria Oliver, Blanca Huergo and Anna Cabré .; and video interventions by Jane Goodall, English ethologist and UN Messenger of Peace, a pioneer in the study of wild chimpanzees; Jen Herranz, FP student, videogame creator and entrepreneur; and Gitanjali Rao, inventor and Girl of the Year according to TIME Magazine and the European Commissioner for Research, Innovation, Education, Culture and Youth, Mariya Gabriel.

Women and innovation report presentation

Posted by a3p on

The Ministry of Science and Innovation presents the first report prepared by the Women, Science and Innovation Observatory (OMCI).


6:30 p.m. Welcome.

Pedro Duque, Minister of Science and Innovation.

18: 40h Results and conclusions of the report “Women and innovation 2020”.

Teresa Riesgo, General Secretariat of Innovation. Ministry of Science and Innovation.

7:00 pm Roundtable discussion.


Antonio Calvo, Scientific journalist.


• Montserrat Calleja, Researcher of the Higher Council for Scientific Research, CSIC.

• Marta Martínez, President of IBM Spain.

• Lina Gálvez, Deputy of the European Parliament.


Save the date! Bionanomechanics conference, On-line, 4th-7th May, 2021

Posted by a3p on

The Bionanomechanics conference aims at offering, every two years, a forum for communication and discussion of the most striking results in the fastly advancing field of mechanobiology. Communications on recent advancements in mechanical biomarkers from their diverse aspects, from technology developments to new proof of concept results in disease diagnosis and prognosis are also welcome. Mechanical fingerprinting of viruses, bacteria and cancer cells will be a highlight of this inaugural conference.

 We welcome submissions on the following topics 

  • Technologies for measuring stiffness of bioanalytes
  • Virus and bacteria mechanobiology
  • Cell mechanobiology
  • Nanomechanical spectrometry

    This conference receives funding from FET Proactive VIRUSCAN H2020 project (No. 731868).

    For more information, please visit: